University of Birmingham
Investigations into parthenolide and boronic acid oxidation towards prodrug development
Abstract
dc:description.abstractCancer is one of the leading causes of death worldwide. Current chemotherapy treatments display off-target effects leading to side effects. Through exploiting the intrinsic differences between healthy cells and cancerous cells, more targeted therapies can be developed using boronic ester oxidation chemistry. Examined in this work are the efforts made into understanding the fundamentals of boronic ester oxidation chemistry, ultimately to inform design of cancer therapy prodrugs. For a starting lead compound, as many drugs on the market are derived from natural products, this work also discusses the scope for using parthenolide as a leukaemia therapy. Supporting information for the thesis can be accessed https://edata.bham.ac.uk/966/
Degree
thesis:*- Name dc:type.qualificationname
- d_ph
- Level dc:type.qualificationlevel
- d_ph
- Grantor dc:publisher.institution
- University of Birmingham
- Year dc:date.issued
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Quy, Alexander S.
Subjects
dc:subject × 3Rights
- Language dc:language.dcterms_iso639_2
- eng